Allergy test length may fuel gut bacteria resistance in children
NCT ID NCT04062344
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at children aged 0-18 who had mild, delayed allergic reactions to beta-lactam antibiotics (like amoxicillin). Researchers compared short (1-4 days) and long (5-8 days) oral drug challenge tests to see if longer testing increased the growth of antibiotic-resistant bacteria in the gut. Rectal swabs were taken before and after the test to check for resistant germs. The goal was to understand if longer testing poses a hidden risk of promoting superbugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors choose safer testing durations for children with suspected beta-lactam allergies, reducing the risk of antibiotic resistance.
What could go wrong
This is a small, completed observational study with only 50 participants. It does not test a treatment, so it cannot directly change clinical practice without further research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BETALACTAMS HYPERSENSITIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker-Enfants Malades
Paris, Paris, 75015, France